We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00184769
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : February 27, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S